MedPath

LACTULOSE

10 g/15 mL

Approved
Approval ID

6619b25c-26b7-4c43-8c4f-9d33a23c61ca

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 30, 2020

Manufacturers
FDA

Lannett Company, Inc.

DUNS: 002277481

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LACTULOSE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0527-5125
Application NumberANDA075993
Product Classification
M
Marketing Category
C73584
G
Generic Name
LACTULOSE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 30, 2020
FDA Product Classification

INGREDIENTS (5)

LACTULOSEActive
Quantity: 10 g in 15 mL
Code: 9U7D5QH5AE
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LACTULOSE - FDA Drug Approval Details